A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined rTMS and BCI Training

October 30, 2019 updated by: University of Minnesota

A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined Repetitive Transcranial Magnetic Stimulation and Brain-Computer Interface Training

The purpose of this study is to determine whether the combination of low frequency repetitive transcranial magnetic stimulation (rTMS) and motor-imagery-based brain computer interface (BCI) training is effective for enhancing motor recovery after stroke.

The PI's hypothesis is that, in comparison with traditional physical therapy alone, subjects receiving supplementary rTMS and BCI training will show greater functional improvements in hand motor ability over time as well as recovery of normal motor connectivity patterns.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The goal of the present study is to develop and evaluate a brain based approach to improve motor recovery after stroke, by combining rTMS and BCI training. Treatments will consist of low frequency rTMS applied to the contralesional hemisphere, followed by BCI training to encourage activity within the lesioned hemisphere. The primary objective of this study is to test the main hypothesis above in a stroke patient population. Subjects will also undergo a period of BCI only treatments after completion of the combined rTMS and BCI portion.

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • Clinical and Translational Science Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18-70 years of age
  • Cortical or subcortical stroke with isolated unilateral motor paresis
  • At least 3 months but no greater than 12 months post stroke and in stable conditions as judged by patient's physician
  • Impaired hand function compared to nonparetic side but at least 10 degrees of active finger extension
  • Able to ambulate at least 50 feet with minimal stand-by assistance
  • Upper Extremity Fugl Meyer (Fugl-Meyer et al., 1975) score of greater than or equal to 20 out of 66
  • Beck Depression Inventory (Beck et al., 1961) less than or equal to 19 out of 63
  • Mini-mental State Examination score (Folstein et al., 1975) greater than or equal to 24 out of 30
  • Must have an ipsilesional motor-evoked potential (MEP) in response to TMS
  • Must be stable outpatients currently undergoing rehabilitation consistent with the current standards of care
  • Must be able to communicate clearly in English
  • Must be able to provide consent in writing.

Exclusion Criteria:

  • Personal history of epilepsy or seizures within the past 2 years
  • Previous surgical procedure to the spinal cord
  • Any MRI incompatible devices
  • Pregnancy
  • Claustrophobia
  • Breathing disorder
  • Hearing problems or ringing in the ears
  • Bilateral motor paresis or paralysis or those patients that would require significant medical monitoring or management beyond that of a stable outpatient
  • Cognitive deficits, other non-motor neurological impairment, bilateral motor paresis or paralysis or those patients that would require significant medical monitoring or management beyond that of a stable outpatient

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Subjects receiving standard-of-care physical therapy only.
Sham Comparator: Sham rTMS + Real BCI Training
Subjects will receive sham rTMS followed by real BCI training.
Device: rTMS
Low frequency rTMS (either real or sham) will be applied to the contralesional hemisphere at a rate of 1Hz for 10 minutes.
Behavioral: BCI Training
BCI training will consist of a series of EEG-based motor-imagery tasks with virtual feedback presented on a computer screen.
Active Comparator: Real rTMS + Real BCI Training
Subjects will receive real rTMS followed by real BCI training.
Device: rTMS
Low frequency rTMS (either real or sham) will be applied to the contralesional hemisphere at a rate of 1Hz for 10 minutes.
Behavioral: BCI Training
BCI training will consist of a series of EEG-based motor-imagery tasks with virtual feedback presented on a computer screen.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Cortical Excitability and Cortical Activation Patterns as Measured by MRI and Functional MRI
Time Frame: Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks)
The MRI and functional MRI will evaluate the extent to which cortical areas are recruited both during rest and during movement related tasks. This is quantified by a laterality index, calculated as the ratio of activations of ipsi- and contra-lesional precentral gyri during a paretic hand tracking task. A LI of -1 corresponds to entirely contralesional activation, while a value of +1 corresponds to entirely ipsilesional activation.
Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Hand Motor Function as Measured by the Box and Block Test
Time Frame: Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks)
Performance on the box and block test with the paretic hand, quantified as the number of 2.5 cm^3 cubes grasped, lifted, and released to transfer between compartments correctly within 60 seconds.
Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks)
Changes in Paretic Hand Motor Function as Measured by the Finger Tracking Test
Time Frame: Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks)
The finger tracking test evaluates the subject's ability to track an oscillating wave with either their paretic or non-paretic finger. Subjects wore custom electro-goniometer braces on each hand, each of which included a potentiometer signaling extension and flexion of the index finger metacarpophalangeal joint. Subjects were presented with target stimuli with a random sinusoidal waveform and were instructed to move the corresponding index finger to match the target trace as the cursor moved across the screen with constant velocity. Performance was quantified by an accuracy index, calculated using the ratio of the error to the standard deviation of the target, normalized to the range of motion for each subject.
Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks)
Changes in Inter-hemispheric Inhibition
Time Frame: Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks)
Inter-hemispheric Inhibition was evaluated using paired-pulse TMS both for the stroke hemisphere to non-stroke hemisphere direction as well as for the non-stroke hemisphere to the stroke hemisphere direction. IHI was measured by applying TMS to identified left and right motor hotspots at 1 mV threshold intensity, or 130% of the RMT if 1 mV threshold could not be identified, with single unilateral pulses and paired bilateral pulses. IHI was quantified by comparing the paired-pulse peak-to-peak motor evoked potential amplitudes to the corresponding single pulse MEP amplitudes for each direction of stimulation (ipsi- to contra-lesional and contra- to ipsi-lesional).
Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subject Report of Symptoms
Time Frame: within 12 weeks of participation
The subject report of symptoms assesses whether subject experience any adverse effects as a result of participation in the study.
within 12 weeks of participation
Changes in the Resting Motor Threshold
Time Frame: Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks)
The resting motor threshold is a measure of cortical excitability, and will be recorded for both the stroke and non-stroke hemispheres.
Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Minnesota

Investigators

  • Principal Investigator: Bin He, PhD, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

January 1, 2017

Study Completion (Actual)

June 1, 2017

Study Registration Dates

First Submitted

April 8, 2014

First Submitted That Met QC Criteria

May 5, 2014

First Posted (Estimate)

May 7, 2014

Study Record Updates

Last Update Posted (Actual)

November 1, 2019

Last Update Submitted That Met QC Criteria

October 30, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1306M36401
  • CBET-1264562 (Other Grant/Funding Number: National Science Foundation)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on rTMS

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe